{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:27:18Z","timestamp":1790720838539,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Future prevalence of colonization with extended-spectrum betalactamase (ESBL-) producing\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      in humans and the potential of public health interventions against the spread of these resistant bacteria remain uncertain.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Based on antimicrobial consumption and susceptibility data recorded during\u2009&gt;\u200913\u00a0years in a Swiss region, we developed a mathematical model to assess the comparative effect of different interventions on the prevalence of colonization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Simulated prevalence stabilized in the near future when rates of antimicrobial consumption and in-hospital transmission were assumed to remain stable (2025 prevalence: 6.8% (95CI%:5.4\u20138.8%) in hospitals, 3.5% (2.5\u20135.0%) in the community\n                      <jats:italic>versus<\/jats:italic>\n                      6.1% (5.0\u20137.5%) and 3.2% (2.3\u20134.2%) in 2019, respectively). When overall antimicrobial consumption was set to decrease by 50%, 2025 prevalence declined by 75% in hospitals and by 64% in the community. A 50% decline in in-hospital transmission rate led to a reduction in 2025 prevalence of 31% in hospitals and no reduction in the community. The best model fit estimated that 49% (6\u2013100%) of observed colonizations could be attributable to sources other than human-to-human transmission within the geographical setting.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Projections suggests that overall antimicrobial consumption will be, by far, the most powerful driver of prevalence and that a large fraction of colonizations could be attributed to non-local transmissions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-022-07441-z","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T07:04:25Z","timestamp":1653289465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The impact of public health interventions on the future prevalence of ESBL-producing Klebsiella pneumoniae: a population based mathematical modelling study"],"prefix":"10.1186","volume":"22","author":[{"given":"Luisa","family":"Salazar-Vizcaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kronenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Pl\u00fcss-Suard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger D.","family":"Kouyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viacheslav","family":"Kachalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Troillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Sommerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"issue":"1","key":"7441_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","volume":"19","author":"A Cassini","year":"2019","unstructured":"Cassini A, Hogberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56\u201366.","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"7441_CR2","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","volume":"13","author":"R Laxminarayan","year":"2013","unstructured":"Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13(12):1057\u201398.","journal-title":"Lancet Infect Dis"},{"issue":"10014","key":"7441_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","volume":"387","author":"AH Holmes","year":"2016","unstructured":"Holmes AH, Moore LS, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387(10014):176\u201387.","journal-title":"Lancet"},{"issue":"2","key":"7441_CR4","first-page":"172","volume":"10","author":"JR Zahar","year":"2009","unstructured":"Zahar JR, Lortholary O, Martin C, et al. Addressing the challenge of extended-spectrum beta-lactamases. Curr Opin Investig Drugs. 2009;10(2):172\u201380.","journal-title":"Curr Opin Investig Drugs"},{"key":"7441_CR5","first-page":"895","volume":"7","author":"CR Lee","year":"2016","unstructured":"Lee CR, Lee JH, Park KS, et al. Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front Microbiol. 2016;7:895.","journal-title":"Front Microbiol"},{"issue":"5","key":"7441_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","volume":"18","author":"R Canton","year":"2012","unstructured":"Canton R, Akova M, Carmeli Y, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012;18(5):413\u201331.","journal-title":"Clin Microbiol Infect"},{"key":"7441_CR7","doi-asserted-by":"crossref","unstructured":"Skov RL, Monnet DL. Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds. Euro Surveill. 2016;21(9).","DOI":"10.2807\/1560-7917.ES.2016.21.9.30155"},{"issue":"18","key":"7441_CR8","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1073\/pnas.1503141112","volume":"112","author":"TP Van Boeckel","year":"2015","unstructured":"Van Boeckel TP, Brower C, Gilbert M, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci U S A. 2015;112(18):5649\u201354.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"7441_CR9","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/nrmicro1553","volume":"4","author":"RS Singer","year":"2006","unstructured":"Singer RS, Ward MP, Maldonado G. Can landscape ecology untangle the complexity of antibiotic resistance? Nat Rev Microbiol. 2006;4(12):943\u201352.","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"7441_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nrg2778","volume":"11","author":"RC MacLean","year":"2010","unstructured":"MacLean RC, Hall AR, Perron GG, et al. The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts. Nat Rev Genet. 2010;11(6):405\u201314.","journal-title":"Nat Rev Genet"},{"key":"7441_CR11","unstructured":"European Centre for Disease Prevention and Control (ECDC); http:\/\/ecdc.europa.eu\/en\/healthtopics\/antimicrobial_resistance\/database\/Pages\/map_reports.aspx."},{"key":"7441_CR12","unstructured":"Swiss Center of Antibiotic Resistance (anresis.ch); http:\/\/anresis.ch\/."},{"key":"7441_CR13","doi-asserted-by":"crossref","unstructured":"Kronenberg A, Hilty M, Endimiani A, et al. Temporal trends of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in in- and outpatients in Switzerland, 2004 to 2011. Euro Surveill. 2013;18(21).","DOI":"10.2807\/ese.18.21.20484-en"},{"key":"7441_CR14","unstructured":"Federal Statistical Office. Portraits of the cantons. Valais. https:\/\/www.bfs.admin.ch\/bfs\/en\/home\/statistics\/regional-statistics\/regional-portraits-key-figures\/cantons\/valais.html. Accessed 12 Mar 2019."},{"issue":"46","key":"7441_CR15","first-page":"943","volume":"18","author":"M Gasser","year":"2018","unstructured":"Gasser M, Schrenzel J, Kronenberg A. Aktuelle Entwicklung der Antibiotikaresistenzen in der Schweiz. Swiss Medical Forum. 2018;18(46):943\u20139.","journal-title":"Swiss Medical Forum"},{"issue":"11","key":"7441_CR16","doi-asserted-by":"publisher","first-page":"O831","DOI":"10.1111\/1469-0691.12677","volume":"20","author":"Y Harada","year":"2014","unstructured":"Harada Y, Morinaga Y, Kaku N, et al. In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae. Clin Microbiol Infect. 2014;20(11):O831\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"7441_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153696","volume":"11","author":"TM Ng","year":"2016","unstructured":"Ng TM, Khong WX, Harris PN, et al. Empiric piperacillin-tazobactam versus carbapenems in the treatment of bacteraemia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae. PLoS ONE. 2016;11(4): e0153696.","journal-title":"PLoS ONE"},{"key":"7441_CR18","doi-asserted-by":"crossref","unstructured":"Roger PM, Montera E, Lesselingue D, et al. Risk factors for unnecessary antibiotic therapy: a major role for clinical management. Clin Infect Dis. 2018.","DOI":"10.1093\/cid\/ciy921"},{"key":"7441_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13756-016-0163-y","volume":"6","author":"R Ranjbar","year":"2017","unstructured":"Ranjbar R, Masoudimanesh M, Dehkordi FS, et al. Shiga (Vero)-toxin producing Escherichia coli isolated from the hospital foods; virulence factors, o-serogroups and antimicrobial resistance properties. Antimicrob Resist Infect Control. 2017;6:4.","journal-title":"Antimicrob Resist Infect Control"},{"key":"7441_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.onehlt.2017.11.004","volume":"5","author":"A George","year":"2018","unstructured":"George A. Antimicrobial resistance, trade, food safety and security. One health. 2018;5:6\u20138.","journal-title":"One health"},{"issue":"15","key":"7441_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.15585\/mmwr.mm6615a1","volume":"66","author":"EP Marder","year":"2017","unstructured":"Marder EP, Cieslak PR, Cronquist AB, et al. Incidence and trends of infections with pathogens transmitted commonly through food and the effect of increasing use of culture-independent diagnostic tests on surveillance\u2014foodborne diseases active surveillance network, 10 U.S. Sites, 2013\u20132016. MMWR Morb Mortal Wkly Rep. 2017;66(15):397\u2013403.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"7441_CR22","doi-asserted-by":"crossref","unstructured":"Hassing RJ, Alsma J, Arcilla MS, et al. International travel and acquisition of multidrug-resistant Enterobacteriaceae: a systematic review. Euro Surveill. 2015;20(47).","DOI":"10.2807\/1560-7917.ES.2015.20.47.30074"},{"issue":"8","key":"7441_CR23","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cmi.2016.05.003","volume":"22","author":"EA Reuland","year":"2016","unstructured":"Reuland EA, Sonder GJ, Stolte I, et al. Travel to Asia and traveller\u2019s diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum beta-lactamase-producing Enterobacteriaceae-a prospective cohort study. Clin Microbiol Infect. 2016;22(8):731.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"7441_CR24","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/cid\/ciu957","volume":"60","author":"A Kantele","year":"2015","unstructured":"Kantele A, Laaveri T, Mero S, et al. Antimicrobials increase travelers\u2019 risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis. 2015;60(6):837\u201346.","journal-title":"Clin Infect Dis"},{"key":"7441_CR25","unstructured":"R Core Team (2014). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria."},{"key":"7441_CR26","unstructured":"Soetaert K, Petzoldt T, Setzer R. deSolve: General Solvers for Initial Value Problems of Ordinary Differential Equations (ODE), Partial Differential Equations (PDE), Differential Algebraic Equations (DAE), and Delay Differential Equations (DDE). Secondary deSolve: General Solvers for Initial Value Problems of Ordinary Differential Equations (ODE), Partial Differential Equations (PDE), Differential Algebraic Equations (DAE), and Delay Differential Equations (DDE). http:\/\/cran.r-project.org\/web\/packages\/deSolve\/index.html."},{"key":"7441_CR27","unstructured":"Torsney-Weir T. optim.functions: Standard Benchmark Optimization Functions. Secondary optim.functions: Standard Benchmark Optimization Functions. https:\/\/cran.r-project.org\/web\/packages\/optim.functions\/index.html."},{"key":"7441_CR28","unstructured":"Soetaert K, Petzoldt T. FME: a Flexible Modelling Environment for Inverse Modelling, Sensitivity, Identifiability and Monte Carlo Analysis. Secondary FME: A Flexible Modelling Environment for Inverse Modelling, Sensitivity, Identifiability and Monte Carlo Analysis. https:\/\/cran.r-project.org\/web\/packages\/FME\/index.html."},{"key":"7441_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijid.2018.01.011","volume":"68","author":"G Alvarez-Uria","year":"2018","unstructured":"Alvarez-Uria G, Gandra S, Mandal S, et al. Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae. Int J Infect Dis. 2018;68:50\u20133.","journal-title":"Int J Infect Dis"},{"issue":"7","key":"7441_CR30","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/cid\/cis581","volume":"55","author":"M Hilty","year":"2012","unstructured":"Hilty M, Betsch BY, Bogli-Stuber K, et al. Transmission dynamics of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis. 2012;55(7):967\u201375.","journal-title":"Clin Infect Dis"},{"key":"7441_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fpubh.2020.00179","volume":"8","author":"MJ Struelens","year":"2020","unstructured":"Struelens MJ, Sintchenko V. Editorial: pathogen genomics: empowering infectious disease surveillance and outbreak investigations. Front Public Health. 2020;8:179.","journal-title":"Front Public Health"},{"issue":"9","key":"7441_CR32","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1093\/cid\/cix1015","volume":"66","author":"E van Duijkeren","year":"2018","unstructured":"van Duijkeren E, Wielders CCH, Dierikx CM, et al. Long-term carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in the general population in The Netherlands. Clin Infect Dis. 2018;66(9):1368\u201376.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"7441_CR33","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s10096-014-2142-7","volume":"33","author":"EA Reuland","year":"2014","unstructured":"Reuland EA, Al Naiemi N, Raadsen SA, et al. Prevalence of ESBL-producing Enterobacteriaceae in raw vegetables. Eur J Clin Microbiol Infect Dis. 2014;33(10):1843\u20136.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"7441_CR34","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1093\/jac\/dkx181","volume":"72","author":"APR Wilson","year":"2017","unstructured":"Wilson APR. Sparing carbapenem usage. J Antimicrob Chemother. 2017;72(9):2410\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"7441_CR35","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/jac\/dku479","volume":"70","author":"KY Lew","year":"2015","unstructured":"Lew KY, Ng TM, Tan M, et al. Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting. J Antimicrob Chemother. 2015;70(4):1219\u201325.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"7441_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004340","volume":"11","author":"U Obolski","year":"2015","unstructured":"Obolski U, Stein GY, Hadany L. Antibiotic restriction might facilitate the emergence of multi-drug resistance. PLoS Comput Biol. 2015;11(6): e1004340.","journal-title":"PLoS Comput Biol"},{"issue":"9","key":"7441_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004493","volume":"11","author":"D Nichol","year":"2015","unstructured":"Nichol D, Jeavons P, Fletcher AG, et al. Steering evolution with sequential therapy to prevent the emergence of bacterial antibiotic resistance. PLoS Comput Biol. 2015;11(9): e1004493.","journal-title":"PLoS Comput Biol"},{"issue":"7","key":"7441_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041068","volume":"7","author":"V Sypsa","year":"2012","unstructured":"Sypsa V, Psichogiou M, Bouzala GA, et al. Transmission dynamics of carbapenemase-producing Klebsiella pneumoniae and anticipated impact of infection control strategies in a surgical unit. PLoS ONE. 2012;7(7): e41068.","journal-title":"PLoS ONE"},{"issue":"6","key":"7441_CR39","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1086\/597505","volume":"30","author":"R Friedmann","year":"2009","unstructured":"Friedmann R, Raveh D, Zartzer E, et al. Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol. 2009;30(6):534\u201342.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"7441_CR40","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1086\/522657","volume":"45","author":"AD Harris","year":"2007","unstructured":"Harris AD, Perencevich EN, Johnson JK, et al. Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition. Clin Infect Dis. 2007;45(10):1347\u201350.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"7441_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2125.2011.04161.x","volume":"74","author":"MA Aldeyab","year":"2012","unstructured":"Aldeyab MA, Harbarth S, Vernaz N, et al. The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings. Br J Clin Pharmacol. 2012;74(1):171\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"7441_CR42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1086\/514643","volume":"27","author":"L Piroth","year":"1998","unstructured":"Piroth L, Aube H, Doise JM, et al. Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: are beta-lactamase inhibitors of therapeutic value? Clin Infect Dis. 1998;27(1):76\u201380.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"7441_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173510","volume":"12","author":"SB Jorgensen","year":"2017","unstructured":"Jorgensen SB, Soraas A, Sundsfjord A, et al. Fecal carriage of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae after urinary tract infection\u2014a three year prospective cohort study. PLoS ONE. 2017;12(3): e0173510.","journal-title":"PLoS ONE"},{"issue":"8","key":"7441_CR44","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3109\/00365548.2011.653582","volume":"44","author":"J Tham","year":"2012","unstructured":"Tham J, Walder M, Melander E, et al. Duration of colonization with extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers\u2019 diarrhoea. Scand J Infect Dis. 2012;44(8):573\u20137.","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"7441_CR45","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1473-3099(16)30319-X","volume":"17","author":"MS Arcilla","year":"2017","unstructured":"Arcilla MS, van Hattem JM, Haverkate MR, et al. Import and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. Lancet Infect Dis. 2017;17(1):78\u201385.","journal-title":"Lancet Infect Dis"},{"key":"7441_CR46","doi-asserted-by":"crossref","unstructured":"Suetens C, Latour K, Karki T, et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill. 2018;23(46).","DOI":"10.2807\/1560-7917.ES.2018.23.46.1800516"},{"issue":"18","key":"7441_CR47","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","volume":"379","author":"SS Magill","year":"2018","unstructured":"Magill SS, O\u2019Leary E, Janelle SJ, et al. Changes in prevalence of health care-associated infections in U.S. Hospitals. N Engl J Med. 2018;379(18):1732\u201344.","journal-title":"N Engl J Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07441-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07441-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07441-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T07:05:24Z","timestamp":1653289524000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07441-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7441"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07441-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/19012765","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,23]]},"assertion":[{"value":"9 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As the analysis was performed on anonymized non-genetic surveillance data, ethical consent was not required according to the Swiss law for research on humans.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"487"}}